MicroRNA-29b targets ADAM12 and 19 to regulate the extracellular matrix in lamina cribrosa cells
Cell and Tissue Research · 2025
DOI: 10.1007/s00441-025-04006-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Tissue Research, 2025. Verfasst von Aoife Smyth und 5 weiteren Autor:innen. Beteiligte Einrichtung: UCD Clinical Research Centre, Mater Misericordiae University Hospital, Eccles St, Phibsborough, Dublin, Ireland. smythaoife1993@gmail.com. Hauptthemen laut MEDLINE: ADAM12 Protein, MicroRNAs, ADAM Proteins, Extracellular Matrix. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCD Clinical Research Centre, Mater Misericordiae University Hospital, Eccles St, Phibsborough, Dublin, Ireland. smythaoife1993@gmail.com.
- Genomic Medicine, Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland, UK.
- UCD Clinical Research Centre, Mater Misericordiae University Hospital, Eccles St, Phibsborough, Dublin, Ireland.
- UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Zitieren
APA
Smyth, A., Callaghan, B., Irnaten, M., Andrews, D., Willoughby, C. E., & O'Brien, C. (2025). MicroRNA-29b targets ADAM12 and 19 to regulate the extracellular matrix in lamina cribrosa cells. Cell and Tissue Research. https://doi.org/10.1007/s00441-025-04006-9
Vancouver
Smyth A, Callaghan B, Irnaten M, Andrews D, Willoughby CE, O'Brien C. MicroRNA-29b targets ADAM12 and 19 to regulate the extracellular matrix in lamina cribrosa cells. Cell and Tissue Research. 2025. doi:10.1007/s00441-025-04006-9
BibTeX
@article{Smyth2025,
author = {Smyth, Aoife and Callaghan, Breedge and Irnaten, Mustapha and Andrews, Darrell and Willoughby, Colin E and O'Brien, Colm},
title = {MicroRNA-29b targets ADAM12 and 19 to regulate the extracellular matrix in lamina cribrosa cells},
journal = {Cell and Tissue Research},
year = {2025},
doi = {10.1007/s00441-025-04006-9}
}
EUVIMED